PMDA drug package insert
ドボベットフォーム
PMDA Prescription drug · レオファーマ株式会社 · package insert Dec 2, 2024
Key facts
| Brand names | ドボベットフォーム |
|---|---|
| Nonproprietary names | カルシポトリオール水和物・ベタメタゾンジプロピオン酸エステル |
| Companies | 製造販売元／レオファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 尋常性乾癬治療剤 |
| Therapeutic category codes | 872699 |
| YJ codes | 2699802R1021 |
| Approval numbers | 30300AMX00001 |
| Package insert edition | 第3版 |
| Package insert date | Dec 2, 2024 |
| PMDA document key | 870206_2699802R1021_1 |
| PMDA company code | 870206 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: